You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
報道指有人重覆接種新冠疫苗 政府呼籲市民遵照政府安排接種
阿思達克 07-20 08:29
早前有報道指,一名男子在外地完成接種兩劑新型肺炎疫苗後,在本港再多接種兩劑疫苗,政府發言人呼籲市民應當遵照政府安排接種新型肺炎疫苗,指目前本港獲授權作緊急使用並透過政府疫苗接種計劃提供兩款新型肺炎疫苗,根據政府安排,未曾接種任何新型肺炎疫苗人士需接種兩劑疫苗,曾感染新型肺炎人士只需接種一劑疫苗,曾於本港以外地方接種第一劑疫苗的抵港人士則須向負責接種的醫療服務提供者如實交待有關首劑疫苗等詳情後,方會獲考慮安排接種第二劑疫苗。至於已於本港以外地方完成整個疫苗接種程序的抵港人士,無須再接種更多劑量的新型肺炎疫苗。

報道指,有關人士在外地完成接種兩劑新型肺炎疫苗,並於抵港後刻意向疫苗接種中心醫護人員隱瞞已完成接種新型肺炎疫苗的事實,聲稱自己屬政府疫苗接種計劃下的合資格接種人士,而不誠實地取得在本港疫苗接種中心再多接種兩劑疫苗的利益。有關人士的行爲除了有機會對自身健康構成風險,同時亦會牽連爲其接種疫苗的醫護人員,更嚴重浪費珍貴的疫苗資源。政府譴責這種罔顧他人、極度自私和不負責任的行爲。

發言人指,有關行爲可能涉及有人以失實陳述及欺騙手段獲取利益,並構成刑事罪行。政府會進行調查並考慮採取適當法律行動,必要時會起訴相關人士,亦不排除會考慮不爲相關人士提供在香港接種疫苗的紀錄證明。發言人並強調,一如其他地方的疫苗接種計劃,政府無法事先準確掌握市民在本港以外地方的疫苗接種紀錄。市民有責任在本港接種疫苗時,就其健康和疫苗接種情況如實陳述。向負責接種疫苗的醫護人員作出失實陳述,不但可能危害自身健康,更可能負上刑事責任,呼籲大家遵照政府安排接種新型肺炎疫苗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account